Table 2.
LDLc levels prior to STEMI, during STEMI admission, and control LDL levels after STEMI.
Global | Men | Women | p Value | |
---|---|---|---|---|
preSTEMI | ||||
<116 | 40 (10.9%) | 34 (11.2%) | 6 (17.1%) | 0.7979 |
116–154.9 | 56 (15.3%) | 46 (15.2%) | 10 (28.6%) | |
155–189.9 | 81 (22.1%) | 68 (22.4%) | 13 (20.6%) | |
≥190 | 28 (7.7%) | 22 (7.26%) | 6 (9.5%) | |
Unavailable | 161 (43.9%) | 133 (43.9%) | 28 (44.4%) | |
At STEMI | ||||
<116 | 177 (48.4%) | 144 (47.5%) | 33 (52.4%) | 0.7069 |
116–154.9 | 101 (27.6%) | 92 (30.4%) | 9 (14.3%) | |
155–189.9 | 40 (10.9%) | 31 (10.2%) | 9 (14.3%) | |
≥190 | 11 (3%) | 10 (3.3%) | 1 (1.6%) | |
Unavailable | 37 (10.1%) | 26 (8.6%) | 11 (17.5%) | |
postSTEMI | Global (344) | |||
<55 | 82 (23.8%) | 70 (24.1%) | 12 (22.2%) | 0.6912 |
55–70 | 63 (18.3%) | 52 (17.9%) | 11 (20.4%) | |
70–116 | 109 (31.7%) | 89 (30.7%) | 20 (37%) | |
116–190 | 16 (4.65%) | 14 (4.8%) | 2 (3.7%) | |
Unavailable | 74 (21.5%) | 65 (22.4%) | 9 (16.7%) |